3 Profitable S&P 500 Stocks With Room to Run: NOW, BSX, COO
ServiceNow (NOW), Boston Scientific (BSX) and The Cooper Companies (COO) have been selected as the top picks with a high net income ratio.
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)
Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.
Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand
Boston Scientific (BSX) posted an increase in second-quarter earnings and sales on the back of growing demand for its heart devices.
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago.
Boston Scientific Q2 Earnings Preview: Can The Rally Continue?
Boston Scientific is set to report Q2 earnings on July 24th. Growth is benefiting from the launch of recent FDA-approved medtech products. We highlight the themes to watch into the second half of t...
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider
Boston Scientific (BSX) reachead $78.02 at the closing of the latest trading day, reflecting a +0.42% change compared to its last close.
Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Boston Scientific (BSX) closed at $77.01, marking a +0.01% move from the previous day.
4 Medical Product Stocks to Buy From a Recovering Industry
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised...
Boston Scientific Buys Silk Road Medical for $1.26 Billion
Shares of Silk Road Medical (SILK) soared in intraday trading Tuesday after Boston Scientific (BSX) announced it was buying the medical device maker for about $1.26 billion.
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Boston Scientific (BSX) closed at $75.57, marking a +0.76% move from the previous day.
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
Boston Scientific (BSX) mCRM System Study Outcome Favorable
Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.
Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation (BSX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Boston Scientific Corporation (NYSE:B...
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts oft...
Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts
Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.
Related Companies